Contract Win

RNS Number : 2045C
Rosslyn Data Technologies PLC
15 January 2015
 



15 January 2015

 

Rosslyn Data Technologies plc

("Rosslyn" or "the Company")

 

Contract Win

 

Global Pharmaceutical Company adopts RAPid Analytics Platform

 

Rosslyn Data Technologies plc (AIM: RDT), a leading global data technology company announces that Rosslyn Analytics Ltd, the Company's wholly owned subsidiary, has  won a significant new contract with one of the world's largest pharmaceutical companies.  The contract is for an initial period of 12 months, with the potential to expand into multiple other areas which would enhance the total revenue of the contract. The contract value puts this new client in the top 10 per cent of the Group's highest value contracts.

Rosslyn was awarded the contract following a competitive 'proof of concept', which was carried out in December 2014. This demonstrated the advantages of the Company's proprietary RAPid platform against other alternatives. The client has data in multiple languages and formats, with its quality and completeness being inconsistent.  This is further complicated by the vast volume of the data and the speed at which the data is being added and changing. 

The client chose Rosslyn's RAPid platform for its ability to collect all this data, and then translate, cleanse and augment it by filling in gaps and adding other data sets to make the information more consistent and valuable. The Directors believe that this not only enables the client to solve its technical challenges but provides it with a foundation of data which it can exploit in multiple scenarios such as operational analysis, financial analysis, risk analysis and compliance reporting. This use of the RAPid platform materially accelerates the transformation of data and delivers the processed information into the hands of all decision-makers accurately and efficiently which helps to deliver significant savings to the client.

Charles Clark, Chief Executive of Rosslyn, said,

''We are thrilled to have won this major contract with one of the largest pharmaceutical corporations in the world, giving us the opportunity to work with this organisation in an area of activity which is central to their risk and performance analytics throughout their global supply chain. The deal further increases our presence in this large sector and gives us another landmark name in the Fortune 1000.

"The win is testament to the value we deliver and the strength of the technologies we have developed, as well as the superior performance, scalability and cost effectiveness of our offering."

 

Enquiries:

Rosslyn Data Technologies plc

Charles Clark, Chief Executive Officer

Francis Reid, Chief Financial Officer

+44(0)20 7138 3204




Blytheweigh - Financial PR

Tim Blythe

 

+44(0)20 7138 3205

+44(0) 7816 924 626


Alex Shilov

+44(0)20 7138 3553

+44(0) 7989 394 027




Cenkos Securities -

Nominated Adviser, Broker

Stephen Keys

Mark Connelly

Michael Johnson

+44(0)20 7397 8926

 

 

Notes to Editors

Rosslyn Data Technologies plc, (AIM: RDT), a leading provider of a Cloud-based enterprise data analytics platform, was founded in 2005 by Charles Clark and Hugh Cox. Business Intelligence was ranked first in the top ten technology priorities for Chief Information Officers in 2012 by Gartner. The Company provides analytical services by combining four key technologies: data extraction; cleansing; enrichment; and visualisation, through a single cloud platform enabling users with detailed data to make more informed decisions. Rosslyn's RAPid platform is the Group's primary product available to its multinational customers, including Aberdeen Asset Management plc, Babcock Corporate Services plc, Xerox Business Services and Coca-Cola Enterprises, Inc. Rosslyn Data Technologies plc is the ultimate holding company of the Group and owns 100 per cent. of Rosslyn Analytics Limited.

Further information can also be found on the Company's website at:  www.rosslynanalytics.com

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
CNTBIMLTMBJBBBA
UK 100

Latest directors dealings